|Articles|July 1, 2013
- BioPharm International-07-01-2013
- Volume 26
- Issue 7
BioPharm International, July 2013 Issue (PDF)
Click the title above to open the BioPharm International July 2013 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 12 years ago
The Pains of Changeover 12 years ago
QbD and PAT in Upstream and Downstream Processingover 12 years ago
EU Battles Medicine Shortagesover 12 years ago
Outsourced Training: A Primerover 12 years ago
Report from Brazilover 12 years ago
What Happened to Outsourcing in Asia?over 12 years ago
Essentials in Stability Analysis and Expiry Determinationover 12 years ago
Kinetic Analysis of Antibodies from Different Cultured Mediaover 12 years ago
FDA Urges Greater Focus on Contractor Qualityover 12 years ago
IPO Market Heats Up for Life-Sciences CompaniesNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5
